Heparin anticoagulation
Phase 3Small molecule
Heparin anticoagulation is one of 2 small molecule programs targeting Extracorporeal Membrane Oxygenation. It is currently in Phase 3.
1
Indications
2
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
1 competitor in Extracorporeal Membrane Oxygenation
#DrugCompanyPhaseTrials
1Ciprofol
Haisco Pharmaceutical Group Co., Ltd.Phase 3
Heparin anticoagulation
UUniversity Medical Centre Ljubljana
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Extracorporeal Membrane Oxygenation1 trial
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
Active, not recruiting·—·Phase 4·NCT04496362·100 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Heparin anticoagulation. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details